FDA Advisers Vote to Replace Original COVID Vaccine with Bivalent Boosters Despite Lack of Clinical Trial Data
Advisers to the U.S. Food and Drug Administration (FDA) on Thursday voted unanimously to replace the original Pfizer and Moderna primary series mRNA COVID-19 vaccines with the bivalent boosters designed to target Omicron variants. The bivalent mRNA boosters — authorized
Read More